Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Finished Drug Prices
NA
1. Bcp30643
Molecular Weight | 233.55 g/mol |
---|---|
Molecular Formula | Fe3H2O4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 0 |
Exact Mass | 233.800115 g/mol |
Monoisotopic Mass | 233.800115 g/mol |
Topological Polar Surface Area | 74.6 Ų |
Heavy Atom Count | 7 |
Formal Charge | 0 |
Complexity | 10.3 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 2 | |
---|---|
Drug Name | Feraheme |
PubMed Health | Parenteral Mineral/Trace Mineral Combination (Injection) |
Drug Classes | Anticonvulsant, Laxative, Hyperosmotic, Nutritive Agent, Parenteral Mineral-Trace Mineral, Renal-Urologic Agent |
Drug Label | Feraheme, an iron replacement product, is a non-stoichiometric magnetite (superparamagnetic iron oxide) coated with polyglucose sorbitol carboxymethylether. The overall colloidal particle size is 17-31 nm in diameter. The chemical formula of Feraheme... |
Active Ingredient | Ferumoxytol |
Dosage Form | Solution |
Route | Intravenous |
Strength | eq 510mg iron/17ml (eq 30mg iron/ml) |
Market Status | Prescription |
Company | Amag Pharms |
2 of 2 | |
---|---|
Drug Name | Feraheme |
PubMed Health | Parenteral Mineral/Trace Mineral Combination (Injection) |
Drug Classes | Anticonvulsant, Laxative, Hyperosmotic, Nutritive Agent, Parenteral Mineral-Trace Mineral, Renal-Urologic Agent |
Drug Label | Feraheme, an iron replacement product, is a non-stoichiometric magnetite (superparamagnetic iron oxide) coated with polyglucose sorbitol carboxymethylether. The overall colloidal particle size is 17-31 nm in diameter. The chemical formula of Feraheme... |
Active Ingredient | Ferumoxytol |
Dosage Form | Solution |
Route | Intravenous |
Strength | eq 510mg iron/17ml (eq 30mg iron/ml) |
Market Status | Prescription |
Company | Amag Pharms |
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-01-25
Pay. Date : 2022-12-15
DMF Number : 37265
Submission : 2022-07-18
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39032
Submission : 2023-10-24
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-02-12
Pay. Date : 2013-11-21
DMF Number : 27718
Submission : 2013-11-26
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39032
Submission : 2023-10-24
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-02-12
Pay. Date : 2013-11-21
DMF Number : 27718
Submission : 2013-11-26
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2023-01-25
Pay. Date : 2022-12-15
DMF Number : 37265
Submission : 2022-07-18
Status : Active
Type : II
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
About the Company : Established in 1994, Rochem is a distributor of pharmaceutical, food, nutritional and animal health ingredients to some of the largest companies in the world. It sources high-quali...
About the Company : Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & F...
About the Company : We introduce ourselves as manufacturer of Active Pharmaceutical Ingredients (API) and intermediates with a professional approach that is aimed at finest results. We have etched a r...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
The acquisition adds AMAG's key products Feraheme®, Makena® and Ciraparantag to Covis' pipeline as it carries out its mission of expanding patient access to much needed therapies.
Lead Product(s): Ferumoxytol
Therapeutic Area: Hematology Brand Name: Feraheme
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Covis Pharma
Deal Size: $647.0 million Upfront Cash: $647.0 million
Deal Type: Acquisition November 16, 2020
Lead Product(s) : Ferumoxytol
Therapeutic Area : Hematology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Covis Pharma
Deal Size : $647.0 million
Deal Type : Acquisition
Covis Group Completes Acquisition of AMAG Pharmaceuticals
Details : The acquisition adds AMAG's key products Feraheme®, Makena® and Ciraparantag to Covis' pipeline as it carries out its mission of expanding patient access to much needed therapies.
Brand Name : Feraheme
Molecule Type : Small molecule
Upfront Cash : $647.0 million
November 16, 2020
Details:
With this deal, Covis gains access to AMAG’s two commercial therapies, Makena, indicated for women with risk of preterm birth in singleton pregnancies and Feraheme indicated treat iron deficiency anaemia in CKD patients and for whom oral iron is not suitable or ineffective.
Lead Product(s): Ferumoxytol
Therapeutic Area: Hematology Brand Name: Feraheme
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Covis Pharma
Deal Size: $647.0 million Upfront Cash: $647.0 million
Deal Type: Acquisition October 01, 2020
Lead Product(s) : Ferumoxytol
Therapeutic Area : Hematology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Covis Pharma
Deal Size : $647.0 million
Deal Type : Acquisition
Covis Group Announces Agreement to Acquire AMAG Pharmaceuticals
Details : With this deal, Covis gains access to AMAG’s two commercial therapies, Makena, indicated for women with risk of preterm birth in singleton pregnancies and Feraheme indicated treat iron deficiency anaemia in CKD patients and for whom oral iron is not su...
Brand Name : Feraheme
Molecule Type : Small molecule
Upfront Cash : $647.0 million
October 01, 2020
20 Jan 2021
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206604
12 Feb 2016
// TWOFOUR INSIGHT
http://twofourinsight.com/analyzing-data-earliest-market-entry-subsequent-anda-filers/
29 Dec 2014
// Press Release AMAG PHARMACEUTICALS
http://ir.amagpharma.com/phoenix.zhtml?c=61596&p=irol-newsArticle&id=2002105
Global Sales Information
Main Therapeutic Indication : Hematology
Currency : USD
2019 Revenue in Millions : 168
2018 Revenue in Millions : 135
Growth (%) : 24
Market Place
Reply
24 Feb 2022
Reply
23 Sep 2021
Reply
30 May 2019
Reply
29 Mar 2019
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?